Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-06-12 Sale | 2025-06-16 9:00 pm | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 425,621 | $20.74 | $8,829,333 | 2,119,060 (Indirect Direct) | View |
| 2024-12-23 Purchase | 2024-12-26 4:01 pm | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 11,085 | $3.2 | $35,472 | 328,338 (Indirect Direct) | View |
| 2024-03-18 Sale | 2024-03-19 9:48 pm | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 461,716 | $6.0724 | $2,803,741 | 2,192,112 (Indirect Direct) | View |
| 2024-03-13 Sale | 2024-03-15 9:00 pm | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 1,038,284 | $6.1057 | $6,339,418 | 2,653,828 (Indirect Direct) | View |
| 2021-06-29 Purchase | 2021-07-01 6:29 pm | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 187,500 | $16 | $3,000,000 | 2,834,910 (Direct) | View |
| 2021-03-16 Purchase | 2021-03-18 4:35 pm | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 1,142,857 | $1.75 | $2,000,000 | 3,159,879 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 53,172 | $1.67 | 2,119,060 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 10,000 | $5 | 2,119,060 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 53,837 | $3.66 | 2,119,060 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A 2026-01-28 | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 332,680 | $0 | 2,119,060 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 9,000 | $5.96 | 2,119,060 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 37,541 | $5.4 | 2,119,060 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 55,000 | $2.35 | 2,119,060 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 17,500 | $4.91 | 2,119,060 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 51,630 | $3.35 | 2,119,060 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 30,000 | $3.89 | 2,119,060 (Direct) | View |
| 2025-06-13 Exercise | 2025-06-16 9:00 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 15,000 | $2.915 | 2,119,060 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:20 pm | N/A 2035-06-04 | Elevation Oncology Inc. | ELEV | ELMS STEVE Director | 35,000 | $0 | 35,000 (Indirect) | View |
| 2025-02-19 Option Award | 2025-02-21 9:05 pm | N/A 2035-02-19 | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 27,168 | $0 | 2,228,280 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 5:20 pm | N/A 2035-02-12 | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 30,000 | $0 | 30,000 (Direct) | View |
| 2024-11-27 Exercise | 2024-12-02 9:02 pm | N/A 2025-01-30 | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 9,000 | $0 | 2,201,112 (Direct) | View |
| 2024-11-27 Exercise | 2024-12-02 9:02 pm | N/A N/A | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 9,000 | $10.8 | 2,201,112 (Indirect) | View |
| 2024-06-13 Option Award | 2024-06-17 4:26 pm | N/A 2034-06-12 | Elevation Oncology Inc. | ELEV | ELMS STEVE Director | 35,000 | $0 | 35,000 (Indirect) | View |
| 2024-02-26 Option Award | 2024-02-28 9:00 pm | N/A 2034-03-26 | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 61,581 | $0 | 3,729,653 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 4:09 pm | N/A 2033-06-15 | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 31,238 | $0 | 31,238 (Indirect) | View |
| 2023-06-06 Option Award | 2023-06-08 9:32 pm | N/A 2033-06-05 | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 8,000 | $0 | 8,000 (Direct) | View |
| 2023-03-06 Option Award | 2023-03-08 9:30 pm | N/A 2033-03-06 | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 77,445 | $0 | 3,719,702 (Direct) | View |
| 2022-06-17 Option Award | 2022-06-22 6:43 pm | N/A 2032-06-16 | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 15,619 | $0 | 15,619 (Indirect) | View |
| 2022-05-24 Option Award | 2022-05-26 4:09 pm | N/A 2032-05-23 | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2022-03-07 Option Award | 2022-03-09 5:59 pm | N/A 2032-03-07 | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 79,758 | $0 | 3,695,429 (Direct) | View |
| 2021-06-29 Conversion | 2021-07-01 6:29 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 12,288,426 | $0 | 2,834,910 (Direct) | View |
| 2021-06-24 Option Award | 2021-06-28 6:18 pm | N/A 2031-06-23 | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP Aisling Capital Partners IV LLC Aisling Capital Partners IV LP ELMS STEVE SCHIFF ANDREW N 10% Owner | 31,238 | $0 | 31,238 (Indirect) | View |
Ownership | 2021-06-24 6:32 pm | N/A N/A | Elevation Oncology Inc. | ELEV | Aisling Capital IV LP ELMS STEVE Aisling Capital Partners IV LLC Aisling Capital Partners IV LP SCHIFF ANDREW N 10% Owner | 0 | $0 | 2,647,410 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 8:38 pm | N/A 2031-06-09 | Zosano Pharma Corp | ZSAN | ELMS STEVE Director | 45,000 | $0 | 2,770,726 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-10 6:55 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 12,658 | $0 | 3,172,537 (Direct) | View |
| 2021-02-25 Option Award | 2021-03-01 9:02 pm | N/A 2031-02-25 | ADMA BIOLOGICS INC. | ADMA | ELMS STEVE Director | 55,000 | $0 | 55,000 (Direct) | View |
Ownership | 2021-02-12 5:12 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 0 | $0 | 2,017,022 (Indirect) | View |
| 2020-05-19 Ownership | 2021-02-12 5:12 pm | N/A N/A | Marker Therapeutics Inc. | MRKR | ELMS STEVE Director | 17,022 | $0 | 2,017,022 (Direct) | View |